Infectious Disease : Fungal

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
65041
A Multicenter, Open, Phase II Study to Estimate the activity and safety of Caspofungin (CASP) in the First-line Treatment of probable and proven Invasive Aspergillosis 'IA) in Patients with Hematological Malignances (HM) or recipients of autologous Haematopoietic Stem Cell Transplantation and those with allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
19951
A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy with AmBisome in Granulocytopenic Cancer Patients with Unexplained Fever Refractory to Empirical Antibacterials
19961
An open randomized comparative phase III study of the efficacy, safety and toleration of Voriconazole versus Amphotericin B in the treatment of acute invasive aspergillosis in immunocompromised patients
19962
An open-label, non-comparative, multicenter study to evaluate the clinical efficacy and safety of Nyotran TM (Liposomal Nystatin) in the treatment of patients with proven of probable Aspergillus infection who are failing standard parenteral antifungal therapy due to lack of response or intolerance to Amphotericin-B or liposomal Amphotericin.
19922
A multicenter double-blind phase III trial of recombinant human macrophage colony-stimulating factor (rM-CSF) or placebo and standard amphotericin-B therapy in patients with definitive or probable invasive candida infection.
199204
Prospective survey of invasive aspergillosis (from February 1, 1993 until February 1, 1994)
19911
An open, multicenter phase III comparative study of the efficacy, safety and tolerance of Fluconazole or iTraconazole in the treatment of cancer patients with oropharyngeal candidiasis

Back to Site-list